The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Scientists have discovered how a key protein helps maintain strong connections between brain cells that are crucial for ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Scientists have discovered how a key protein helps maintain strong connections between brain cells that are crucial for ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

A team of Chicago area scientists discovered that the human pegivirus, a blood-borne virus otherwise not known to cause any specific disease, may be associated with Parkinson’s disease and ...